#news #biotech Novartis’ radioligand hits goal in phase 3 prostate cancer trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis’ radioligand hits goal in phase 3 prostate cancer trial .Novartis’ radioligand hits goal in phase 3 prostate cancer trial
ntaylor
Tue, 03/23/2021 – 07:34

from FierceBiotech: Biotech https://ift.tt/3vN7UkB